Clinical Trial Update: A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 [Phase 3]

View source ↗

Summary

Phase 3 randomized double-blind study evaluating oral polio vaccine and NA-831 for COVID-19 is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars

Drugs mentioned

• NA-831
• Oral polio vaccine (Oral polio vaccine)

Snippet

Sponsor: Biomed Industries, Inc. | Conditions: Covid19, SARS (Severe Acute Respiratory Syndrome) | Phase 3 | Status: UNKNOWN